Expanded Access to EBiSC Catalog of High-Quality iPSC Lines, Accelerating Research into Neuroscience, Oncology, Rare Disease, and More
Piscataway, NJ – Sampled, an integrated analytical laboratory and biorepository, has partnered with the European Bank for Induced Pluripotent Stem Cells (EBiSC) as the sole distributor of their stem cell line catalog to US researchers.
Induced pluripotent stem cells (iPSCs) are the bedrock of many modern research applications. Researchers use them to generate precise disease models for basic research and more precise drug screening applications. iPSC-based therapies are already showing promise in clinical trials for diseases spanning oncology, ophthalmology, hematology/immunology, and neurology. iPSCs are an enduring asset for scientific research, growing in relevance as new technologies and infrastructures facilitate their implementation.
EBiSC is a centralized biobank that maintains iPSCs and their associated data for use by both non-profit and commercial organizations. They currently store over 900 cell lines representing more than 40 diseases and address common challenges facing iPSC researchers by maintaining important GDPR regulatory and legal information. EBiSC performs functional and phenotypic characterization of derived cell lines, which helps to streamline research efforts and reduces the experimental burden on research teams. A highlight of the repository is the EBiSC-NEUR1 iPSC neurons, a doxycycline-inducible cell model that allows researchers to study diverse neuronal lineages. The EBiSC catalog, available at www.EBiSC.org, provides a comprehensive list of available cell lines and associated data.
Sampled has partnered with EBiSC as the sole distributor of their iPSC catalog to US researchers, including EBiSC-NEUR1 iPSC neurons, to support diverse applications across broad therapeutic areas. This partnership improves accessibility to important cell lines and builds on the existing cell line catalogs that Sampled distributes for organizations such as the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH) Stem Cell Center.
Sampled offers a suite of iPSC services, including iPSC reprogramming from fibroblasts and lymphocytes, gene editing, expansion, storage, and quality control. Comprehensive multiomics offerings enable on-site analysis of iPSC lines, spanning genomics, transcriptomics, proteomics, and more.
“I am thrilled to announce the partnership between Sampled and EBiSC to make their valuable iPSC collection available to investigators in the US. We consider this an important and essential addition the stem cell line repository offerings Sampled already provides.”
Mike Sheldon, PhD
Senior Director Scientific Affairs, Sampled
About Sampled
Sampled is a fully integrated laboratory and biorepository with industry-leading storage, sample management, multiomics, cellular services, and custom clinical kitting. Founded in 1999 as RUCDR at Rutgers University, Sampled operates facilities in the US and UK and is CAP accredited and CLIA licensed. Sampled is committed to providing the highest quality sample storage, processing, and analysis services that enable researchers to make new discoveries and advance human health. When combined with state-of-the-art biobanking facilities, these capabilities provide comprehensive scientific solutions that speed time to quality data.
Media Contact
Caroline Mitchell, PhD
Director, Content & Creative Strategy, Sampled
